AdamMBrufskyMD

PubMed

• 1318 citations
  Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
  Joseph A. Sparano, Robert Gray, Della F. Makower, Kathleen I. Pritchard, Kathy S. Albain
  The New England Journal of Medicine. 2018-06-03
• 27 citations
  Outcome of Everolimus-Based Therapy in Hormone-Receptor-Positive Metastatic Breast Cancer Patients After Progression on Palbociclib.
  Ajay Dhakal, Roby Antony Thomas, Ellis G. Levine, Adam Brufsky, Kazuaki Takabe
  Breast Cancer. 2020-07-23
• 69 citations
  Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial
  Kathy S. Albain, Robert Gray, Della F. Makower, Amir Faghih, Daniel F. Hayes
  Journal of the National Cancer Institute. 2021-04-06

Journal Articles

• Molecular Mechanisms Linking High Body Mass Index to Breast Cancer Etiology in Post-Menopausal Breast Tumor and Tumor-Adjacent Tissues  
  Adam M Brufsky, Tari A King, Susan B Brown, Breast Cancer Research and Treatment
• Nab-Paclitaxel plus Carboplatin or Gemcitabine vs Gemcitabine plus Carboplatin as First-Line Treatment for Patients with Triple-Negative Metastatic Breast Cancer: Resu...  
  H Ali, A Brufsky, M Shtivelband, S Gluck, J Miller, R Young, Annals of Oncology
• Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer  
  Matthew P Goetz, Thomas J Saphner, Joseph A Sparano, Lynne I Wagner, Peter M Ravdin, Daniel F Hayes, Adam M Brufsky, Della F Makower, Sunil S Badve, Robert J Gray, Wil..., The New England Journal of Medicine

Lectures

• A Metastatic Breast Cancer Patient with Activating HER2 Exon 20 Insertion Mutation Responds to Poziotinib; A Case Report of Compassionate Drug Use 
  2019 ASCO Annual Meeting - 6/1/2019